A recent study assessed the efficacy of SARS-CoV-2 primary series vaccination, additional initial dose, or booster shot against the SARS-CoV-2 Omicron infection in the nursing home.
"Cases of hospitalisations is also increasing. As it is growing now, there will be no place in hospitals in the next one-and-a-half months. Then it will be difficult to provide treatment," Health Minister Zahid Maleque said
Pfizer, Johnson & Johnson and Moderna each say they have begun work on a new version of their vaccine specifically targeting Omicron in case existing jabs don t work against it
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.